EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

E-vita OPEN NEO in the treatment of acute or chronic aortic pathologies: first interim results of the NEOS study

Konstantinos Tsagakis iD, Joerg Kempfert, Andreas Zierer, Andreas Martens iD, Daniel-Sebastian Dohle, Alessandro Castiglioni, Randolph Hung-Leung Wong, Kazimierz Widenka, Oliver Liakopoulos, Michael A Borger, Aung Ye Oo, Tomas Holubec und 3 weitere

European Journal of Cardio-Thoracic Surgery · 03.06.2024 · 65 (6)

DOI: 10.1093/ejcts/ezae206 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 03.06.2024. Verfasst von Konstantinos Tsagakis und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center, University Hospital Essen, Essen, Germany. Hauptthemen laut MEDLINE: Aortic Dissection, Aortic Aneurysm, Thoracic, Blood Vessel Prosthesis Implantation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JOTEC GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES The aim of this multicentre study was to demonstrate the safety and clinical performance of E-vita OPEN NEO Stent Graft System (Artivion, Inc.) in the treatment of aneurysm or dissection, both acute and chronic, in the ascending aorta, aortic arch and descending thoracic aorta. METHODS In this observational study of 12 centres performed in Europe and in Asia patients were enrolled between December 2020 and March 2022. All patients underwent frozen elephant trunk using E-vita OPEN NEO Stent Graft System. Primary end point was the rate of all-cause mortality at 30 days and secondary end points included further clinical and safety data are reported up to 3–6 months postoperatively. RESULTS A total of 100 patients (66.7% male; mean age, 57.7 years) were enrolled at 12 sites. A total of 99 patients underwent surgery using the E-vita OPEN NEO for acute or subacute type A aortic dissection (n = 37), chronic type A aortic dissection (n = 33) or thoracic aortic aneurysm (n = 29), while 1 patient did not undergo surgery. Device technical success at 24 h was achieved in 97.0%. At discharge, new disabling stroke occurred in 4.4%, while new paraplegia and new paraparesis was reported in 2.2% and 2.2%, respectively. Renal failure requiring permanent (>90 days) dialysis or hemofiltration at discharge was observed in 3.3% of patients. Between discharge and the 3–6 months visit, no patients experienced new disabling stroke, new paraplegia or new paraparesis. The 30-day mortality was 5.1% and the estimated 6-month survival rate was 91.6% (standard deviation: 2.9). CONCLUSIONS Total arch replacement with the E-vita OPEN NEO can be performed with excellent results in both the acute and chronic setting. This indicates that E-vita OPEN NEO can be used safely, including in the setting of acute type A aortic dissection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic DissectionAortic Aneurysm, ThoracicBlood Vessel Prosthesis ImplantationHumansMaleFemaleMiddle AgedAgedChronic DiseaseStentsAcute DiseaseBlood Vessel ProsthesisTreatment OutcomeAorta, ThoracicPostoperative ComplicationsEuropeAdultEndovascular Procedures

Stichwörter der Autor:innen

Antegrade cerebral perfusionAortic arch aneurysmAortic dissectionDistal aortic perfusionE-vita OPEN NEOFrozen elephant trunk procedure

Autor:innen und Institutionen

  • Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center, University Hospital Essen, Essen, Germany.
  • Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany.
  • Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Department of Cardiovascular and Thoracic Surgery, Faculty of Medicine, Johannes Kepler University Linz, Linz, Austria.
  • Department of Cardiovascular and Thoracic Surgery, Wels-Grieskirchen Clinic, Wels, Austria.
  • Clinic of Cardiac Surgery, University Hospital Oldenburg, Oldenburg, Germany.

ORCID-Profile: Konstantinos Tsagakis, Andreas Martens, Martin Grabenwöger

Förderung

  • JOTEC GmbH

Zitieren

APA

Tsagakis, K., Kempfert, J., Zierer, A., Martens, A., Dohle, D. S., Castiglioni, A., Wong, R. H., Widenka, K., Liakopoulos, O., Borger, M. A., Oo, A. Y., Holubec, T., Luehr, M., Legarra Calderón, J. J., & Grabenwöger, M. (2024). E-vita OPEN NEO in the treatment of acute or chronic aortic pathologies: first interim results of the NEOS study. European Journal of Cardio-Thoracic Surgery, 65(6). https://doi.org/10.1093/ejcts/ezae206

Vancouver

Tsagakis K, Kempfert J, Zierer A, Martens A, Dohle DS, Castiglioni A, et al. E-vita OPEN NEO in the treatment of acute or chronic aortic pathologies: first interim results of the NEOS study. European Journal of Cardio-Thoracic Surgery. 2024;65(6). doi:10.1093/ejcts/ezae206

BibTeX
@article{Tsagakis2024,
  author = {Tsagakis, Konstantinos and Kempfert, Joerg and Zierer, Andreas and Martens, Andreas and Dohle, Daniel-Sebastian and Castiglioni, Alessandro and Wong, Randolph Hung-Leung and Widenka, Kazimierz and Liakopoulos, Oliver and Borger, Michael A and Oo, Aung Ye and Holubec, Tomas and Luehr, Maximilian and Legarra Calderón, Juan José and Grabenwöger, Martin},
  title = {E-vita OPEN NEO in the treatment of acute or chronic aortic pathologies: first interim results of the NEOS study},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2024},
  volume = {65},
  number = {6},
  doi = {10.1093/ejcts/ezae206}
}
Kostenlos starten →